Gerard O., OghlakianIlke, SipahiJames C., Fang. (2011) Treatment of Heart Failure With Preserved Ejection Fraction: Have We Been Pursuing the Wrong Paradigm?. Mayo Clinic Proceedings 86 , 531-539 /Oghlakian GO, Sipahi I, Fang JC. Treatment of heart failure with preserved ejection ...
Heart failure with preserved ejection fraction (HFpEF) has grown to become the dominant form of heart failure worldwide, in tandem with ageing of the general population and the increasing prevalences of obesity, diabetes mellitus and hypertension. The clinical syndrome of HFpEF is heterogeneous and ...
"This tells us thatbariatric surgerymay become part of the treatment of patients with heart failure and obesity if there are no major contraindications for the surgery - and that this might be especially important for patients with significant obesity," says the study's lead investigator, cardiolog...
randomized trial of patients with HFpEF (NCT03030235), we evaluated whether the SGLT2 inhibitor dapagliflozin improves the primary endpoint of Kansas City Cardiomyopathy Questionnaire Clinical Summary Score (KCCQ-CS), a measure of heart failure-related health status, at 12 weeks after treatment initi...
Acknowledging the need for increased monitoring of patients at risk for heart failure, Mayo Clinic researchers created an AI-based method to not only monitor patients more closely but also to enhance the diagnosis process. "Currently, we diagnose ventricular dysfunction ― a weak ...
by Mayo Clinic For patients with severe heart failure, an implanted mechanical pump known as a Left Ventricular Assist Device (LVAD) can be a life-sustaining treatment. Even though the technology involves risks, few patients and their families tend to talk explicitly about the "what ifs" before...
References: 1) http://www.medicinenet.com/congestive_heart_failure/article.htm 2) http://www.nlm.nih.gov/medlineplus/ency/article/000158.htm 3) http://www.mayoclinic.org/congestive-heart-failure/treatment.html
Heart failure is a life limiting cardiovascular condition, frequently encountered in the increasingly aged population. People affected endure a symptomatic burden and mortality risk at least equivalent to those associated with common cancers. However, th
It publishes the most important findings on the pathophysiology, diagnosis, treatment, and care of heart failure patients. 中文简介 JACC:心力衰竭是著名的美国心脏病学会杂志 (JACC) 推出的一系列专业期刊之一。 它发表有关心力衰竭患者的病理生理学、诊断、治疗和护理的最重要发现。
Four weeks of treatment with a novel inhaled medication failed to improve exercise capacity, daily activity levels, severity of symptoms or quality of life in patients with a type of heart failure for which no effective treatment options currently exist, according to research presented at the Americ...